Susquehanna Fundamental Investments, LLC Eiger Bio Pharmaceuticals, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$7.82 - $9.23 $185,044 - $218,409	-23,663 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$8.44 - $12.66 $119,864 - $179,797	-14,202 Reduced 37.51%	23,663 $209,000
Q4 2020 Feb 16, 2021	SELL	$7.98 - $12.29 $24,147 - $37,189	-3,026 Reduced 7.4%	37,865 $465,000
Q3 2020 Nov 16, 2020	BUY	$7.96 - $12.42 $242,708 - $378,698	30,491 Added 293.18%	40,891 $333,000
Q2 2020 Aug 14, 2020	BUY	$5.4 - $13.37 $56,160 - $139,048	10,400 New	10,400 $100,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.